Stock swings and valuation woes are learnt to have stalled Swiss pharma giant Novartis's plans to sell its 70.68 per cent stake in Novartis India The Swiss pharmaceutical titan Novartis' much-anticipated exit from its Indian arm has hit turbulent waters, with market volatility and valuation concerns throwing a wrench in the $200 million stake sale, [...]
Novartis is a Switzerland-based multinational medicines company that researches and develops generic and pharmaceutical products for the healthcare industry.